Neurosurgery Devices Market by Product (Neuromodulation(Spinal Cord Stimulation, Deep Brain Stimulation) Neuroendoscopy), Application (Chronic Pain, Depression, Parkinsons, Ischemia, Transnasal Neuroendoscopy), Region - Global Forecast to 2024
出 版 商：MarketsandMarkets
出版日期：2019/09/10
頁 數：121頁
文件格式：PDF
價 格：
USD 5,650 (Single-User License)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
USD 10,000 (Hard copy)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
USD 10,000 (Hard copy)
“The neurosurgery devices market is projected to grow at a CAGR of 13.0% during the forecast period.”
The neurosurgery devices market is projected to reach USD 13.5 billion by 2024 from USD 7.3 billion in 2019, at a CAGR of 13.0% during the forecast period. Growth in this market can be attributed to the rising prevalence of neurological disorders, efforts to develop the application base for neuromodulation, the benefits of neuroendoscopic surgeries over conventional brain surgeries, and the growing prevalence of neurological diseases. However, the high cost of neuroendoscopy procedures and equipment, along with a dearth of a trained workforce, is expected to limit market growth to a certain extent during the forecast period.
“The internal neuromodulation devices segment accounted for the largest share of the neuromodulation devices market in 2018.”
On the basis of product, the neurosurgery devices market is segmented into neuromodulation devices and neuroendoscopy devices. The neuromodulation devices market is further segmented into internal neuromodulation devices and external neuromodulation devices. The internal neuromodulation devices segment accounted for the largest share of the neuromodulation devices market in 2018. The large share of this segment is attributed to the rising number of neurological disorders owing to the rising geriatric population globally.
“The chronic pain applications segment will continue to dominate the spinal cord stimulation applications market during the forecast period.”
On the basis of application, the neurosurgery devices market is segmented into spinal cord stimulation, deep brain stimulation, and neuroendoscopy applications. The spinal cord stimulation applications market is further segmented into chronic pain, failed back surgery syndrome, and ischemia. The chronic pain segment accounted for the largest share of the spinal cord stimulation applications market in 2018. The large share of this segment can be attributed to the growing geriatric population and the increasing incidence of age-related neurological disorders.
“The neurosurgery devices market in the Asia Pacific region is expected to witness the highest growth rate during the forecast period.”
Geographically, the neurosurgery devices market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period, primarily due to the large population in Asia (India and China account for over one-third of the global population) as well as the rising geriatric population in Asian countries.
Breakdown of supply-side primary interviews:
‧ By Company Type: Tier 1: 55%, Tier 2: 20%, and Tier 3: 25%
‧ By Designation: C-level: 35%, Director-level: 25%, and Others: 40%
‧ By Region: North America: 20%, Europe: 25%, APAC: 40%, and the RoW: 15%
Major players in this market include B. Braun Melsungen (Germany), Medtronic (US), Boston Scientific Corporation (US), Nevro Corporation (US), KARL STORZ (Germany), Abbott (US), Ackermann Instrumente (Germany), Hawk (China), Machida Endoscope (Japan), and adeor Medical (Germany).
Research Coverage
This report studies the neurosurgery devices market based on product, application, and region. The report also studies the different factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the neurosurgery devices market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
The neurosurgery devices market is projected to reach USD 13.5 billion by 2024 from USD 7.3 billion in 2019, at a CAGR of 13.0% during the forecast period. Growth in this market can be attributed to the rising prevalence of neurological disorders, efforts to develop the application base for neuromodulation, the benefits of neuroendoscopic surgeries over conventional brain surgeries, and the growing prevalence of neurological diseases. However, the high cost of neuroendoscopy procedures and equipment, along with a dearth of a trained workforce, is expected to limit market growth to a certain extent during the forecast period.
“The internal neuromodulation devices segment accounted for the largest share of the neuromodulation devices market in 2018.”
On the basis of product, the neurosurgery devices market is segmented into neuromodulation devices and neuroendoscopy devices. The neuromodulation devices market is further segmented into internal neuromodulation devices and external neuromodulation devices. The internal neuromodulation devices segment accounted for the largest share of the neuromodulation devices market in 2018. The large share of this segment is attributed to the rising number of neurological disorders owing to the rising geriatric population globally.
“The chronic pain applications segment will continue to dominate the spinal cord stimulation applications market during the forecast period.”
On the basis of application, the neurosurgery devices market is segmented into spinal cord stimulation, deep brain stimulation, and neuroendoscopy applications. The spinal cord stimulation applications market is further segmented into chronic pain, failed back surgery syndrome, and ischemia. The chronic pain segment accounted for the largest share of the spinal cord stimulation applications market in 2018. The large share of this segment can be attributed to the growing geriatric population and the increasing incidence of age-related neurological disorders.
“The neurosurgery devices market in the Asia Pacific region is expected to witness the highest growth rate during the forecast period.”
Geographically, the neurosurgery devices market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period, primarily due to the large population in Asia (India and China account for over one-third of the global population) as well as the rising geriatric population in Asian countries.
Breakdown of supply-side primary interviews:
‧ By Company Type: Tier 1: 55%, Tier 2: 20%, and Tier 3: 25%
‧ By Designation: C-level: 35%, Director-level: 25%, and Others: 40%
‧ By Region: North America: 20%, Europe: 25%, APAC: 40%, and the RoW: 15%
Major players in this market include B. Braun Melsungen (Germany), Medtronic (US), Boston Scientific Corporation (US), Nevro Corporation (US), KARL STORZ (Germany), Abbott (US), Ackermann Instrumente (Germany), Hawk (China), Machida Endoscope (Japan), and adeor Medical (Germany).
Research Coverage
This report studies the neurosurgery devices market based on product, application, and region. The report also studies the different factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the neurosurgery devices market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DESIGN 19
2.2 RESEARCH APPROACH 20
2.2.1 RESEARCH METHODOLOGY STEPS 20
2.2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 21
2.2.2.1 Secondary research 21
2.2.2.2 Secondary sources 21
2.2.2.3 Primary research 22
2.2.2.4 Primary sources 23
2.2.2.5 Key insights from primary sources 23
2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 25
2.5 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 30
4.1 NEUROSURGERY DEVICES: MARKET OVERVIEW 30
4.2 NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE,
2019 VS. 2024 (USD MILLION) 30
4.3 DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 31
4.4 NEUROSURGERY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 32
?
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 33
5.2.1.1 Research into expanding applications of neuromodulation 33
5.2.1.2 Benefits of neuroendoscopic surgery over conventional brain surgery 34
5.2.1.3 Rising prevalence of neurological diseases 35
5.2.2 RESTRAINTS 35
5.2.2.1 High cost of neuroendoscopy procedures and equipment 35
5.2.3 OPPORTUNITIES 35
5.2.3.1 Emerging economies 35
5.2.4 CHALLENGES 36
5.2.4.1 Dearth of trained professionals 36
6 NEUROSURGERY DEVICES MARKET, BY PRODUCT 37
6.1 INTRODUCTION 38
6.2 NEUROMODULATION DEVICES 39
6.2.1 INTERNAL NEUROMODULATION DEVICES 39
6.2.2 SPINAL CORD STIMULATION DEVICES 40
6.2.2.1 SCS devices dominate the internal neuromodulation devices market as they are cost-efficient 40
6.2.3 DEEP BRAIN STIMULATION DEVICES 41
6.2.3.1 Growing prevalence of Parkinson’s disease and other neurological disorders to fuel market growth 41
6.2.4 OTHER INTERNAL NEUROMODULATION DEVICES 42
6.3 EXTERNAL NEUROMODULATION DEVICES 43
6.3.1 RISING DEMAND FOR NONINVASIVE NEUROMODULATION TECHNIQUES TO DRIVE THE ADOPTION OF EXTERNAL NEUROMODULATION DEVICES 43
6.4 NEUROENDOSCOPY DEVICES 44
6.4.1 LOW COST, SMALLER INCISIONS, AND REDUCED HOSPITAL STAY ARE SOME OF THE ADVANTAGES ASSOCIATED WITH NEUROENDOSCOPY DEVICES 44
7 NEUROSURGERY DEVICES MARKET, BY APPLICATION 46
7.1 INTRODUCTION 47
7.2 SPINAL CORD STIMULATION MARKET 47
7.2.1 CHRONIC PAIN 48
7.2.1.1 Spinal cord stimulation is the standard procedure for patients with chronic pain 48
7.2.2 FAILED BACK SURGERY SYNDROME (FBSS) 49
7.2.2.1 Treatments such as chiropractic and acupressure are expected to hamper the growth of the neurosurgery devices market for FBSS 49
7.2.3 ISCHEMIA 50
7.2.3.1 High incidence of ischemia to drive the demand for neurosurgery devices 50
7.3 DEEP BRAIN STIMULATION MARKET 50
7.3.1 PARKINSON’S DISEASE 52
7.3.1.1 Rising incidence of Parkinson’s and the growing number of researches conducted in this field to drive market growth 52
7.3.2 TREMOR 52
7.3.2.1 Rising geriatric population and the high efficacy of DBS to support market growth 52
7.3.3 DEPRESSION 53
7.3.3.1 DBS therapies to treat depression involve activating the brain directly with magnets, implants, and electricity 53
7.3.4 OTHER DBS APPLICATIONS 54
7.4 NEUROENDOSCOPY 54
7.4.1 TRANSNASAL NEUROENDOSCOPY 55
7.4.1.1 Transnasal neuroendoscopy is indicated for biopsies, removal of cysts, and removal of pituitary gland tumors 55
7.4.2 INTRAVENTRICULAR NEUROENDOSCOPY 56
7.4.2.1 Ease of use, increased visibility, and treatment of a large number of neurological conditions—key advantages of intraventricular neuroendoscopy 56
7.4.3 TRANSCRANIAL NEUROENDOSCOPY 57
7.4.3.1 Transcranial approach is more invasive as compared to the transnasal neuroendoscopic approach 57
8 NEUROSURGERY DEVICES MARKET, BY REGION 58
8.1 INTRODUCTION 59
8.2 NORTH AMERICA 60
8.2.1 US 63
8.2.1.1 The US dominates the North American neurosurgery devices market due to the high prevalence of traumatic brain injuries 63
8.2.2 CANADA 66
8.2.2.1 Favorable government initiatives to support market growth in Canada 66
8.3 EUROPE 69
8.3.1 GERMANY 72
8.3.1.1 The strong presence of key neurosurgery equipment manufacturers to support market growth 72
8.3.2 UK 75
8.3.2.1 High burden of brain tumors to fuel market growth 75
8.3.3 FRANCE 77
8.3.3.1 Rising geriatric population and the associated increase in the prevalence of neurological disorders to drive the demand for neurosurgery devices 77
8.3.4 ROE 80
8.4 ASIA PACIFIC 83
8.5 REST OF THE WORLD 87
?
9 COMPETITIVE LANDSCAPE 91
9.1 OVERVIEW 91
9.2 MARKET SHARE ANALYSIS 92
9.2.1 INTRODUCTION 92
9.3 COMPETITIVE LEADERSHIP MAPPING 94
9.3.1 VISIONARY LEADERS 94
9.3.2 INNOVATORS 95
9.3.3 DYNAMIC DIFFERENTIATORS 95
9.3.4 EMERGING COMPANIES 95
9.4 COMPETITIVE SCENARIO 97
9.4.1 PRODUCT LAUNCHES 97
9.4.2 EXPANSIONS 97
9.4.3 ACQUISITIONS 98
9.4.4 JOINT VENTURES 98
10 COMPANY PROFILES 99
(Business overview, Products offered, Recent developments, MNM view)*
10.1 B. BRAUN MELSUNGEN 99
10.2 MEDTRONIC 101
10.3 BOSTON SCIENTIFIC CORPORATION 103
10.4 NEVRO CORPORATION 105
10.5 KARL STORZ 107
10.6 ABBOTT 108
10.7 ACKERMANN INSTRUMENTE 110
10.8 ADEOR MEDICAL 111
10.9 HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS 112
10.10 MACHIDA ENDOSCOPE CO., LTD. 113
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11 APPENDIX 114
11.1 DISCUSSION GUIDE 114
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 117
11.3 AVAILABLE CUSTOMIZATIONS 119
11.4 RELATED REPORTS 119
11.5 AUTHOR DETAILS 120
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DESIGN 19
2.2 RESEARCH APPROACH 20
2.2.1 RESEARCH METHODOLOGY STEPS 20
2.2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 21
2.2.2.1 Secondary research 21
2.2.2.2 Secondary sources 21
2.2.2.3 Primary research 22
2.2.2.4 Primary sources 23
2.2.2.5 Key insights from primary sources 23
2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 25
2.5 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 30
4.1 NEUROSURGERY DEVICES: MARKET OVERVIEW 30
4.2 NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE,
2019 VS. 2024 (USD MILLION) 30
4.3 DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 31
4.4 NEUROSURGERY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 32
?
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 33
5.2.1.1 Research into expanding applications of neuromodulation 33
5.2.1.2 Benefits of neuroendoscopic surgery over conventional brain surgery 34
5.2.1.3 Rising prevalence of neurological diseases 35
5.2.2 RESTRAINTS 35
5.2.2.1 High cost of neuroendoscopy procedures and equipment 35
5.2.3 OPPORTUNITIES 35
5.2.3.1 Emerging economies 35
5.2.4 CHALLENGES 36
5.2.4.1 Dearth of trained professionals 36
6 NEUROSURGERY DEVICES MARKET, BY PRODUCT 37
6.1 INTRODUCTION 38
6.2 NEUROMODULATION DEVICES 39
6.2.1 INTERNAL NEUROMODULATION DEVICES 39
6.2.2 SPINAL CORD STIMULATION DEVICES 40
6.2.2.1 SCS devices dominate the internal neuromodulation devices market as they are cost-efficient 40
6.2.3 DEEP BRAIN STIMULATION DEVICES 41
6.2.3.1 Growing prevalence of Parkinson’s disease and other neurological disorders to fuel market growth 41
6.2.4 OTHER INTERNAL NEUROMODULATION DEVICES 42
6.3 EXTERNAL NEUROMODULATION DEVICES 43
6.3.1 RISING DEMAND FOR NONINVASIVE NEUROMODULATION TECHNIQUES TO DRIVE THE ADOPTION OF EXTERNAL NEUROMODULATION DEVICES 43
6.4 NEUROENDOSCOPY DEVICES 44
6.4.1 LOW COST, SMALLER INCISIONS, AND REDUCED HOSPITAL STAY ARE SOME OF THE ADVANTAGES ASSOCIATED WITH NEUROENDOSCOPY DEVICES 44
7 NEUROSURGERY DEVICES MARKET, BY APPLICATION 46
7.1 INTRODUCTION 47
7.2 SPINAL CORD STIMULATION MARKET 47
7.2.1 CHRONIC PAIN 48
7.2.1.1 Spinal cord stimulation is the standard procedure for patients with chronic pain 48
7.2.2 FAILED BACK SURGERY SYNDROME (FBSS) 49
7.2.2.1 Treatments such as chiropractic and acupressure are expected to hamper the growth of the neurosurgery devices market for FBSS 49
7.2.3 ISCHEMIA 50
7.2.3.1 High incidence of ischemia to drive the demand for neurosurgery devices 50
7.3 DEEP BRAIN STIMULATION MARKET 50
7.3.1 PARKINSON’S DISEASE 52
7.3.1.1 Rising incidence of Parkinson’s and the growing number of researches conducted in this field to drive market growth 52
7.3.2 TREMOR 52
7.3.2.1 Rising geriatric population and the high efficacy of DBS to support market growth 52
7.3.3 DEPRESSION 53
7.3.3.1 DBS therapies to treat depression involve activating the brain directly with magnets, implants, and electricity 53
7.3.4 OTHER DBS APPLICATIONS 54
7.4 NEUROENDOSCOPY 54
7.4.1 TRANSNASAL NEUROENDOSCOPY 55
7.4.1.1 Transnasal neuroendoscopy is indicated for biopsies, removal of cysts, and removal of pituitary gland tumors 55
7.4.2 INTRAVENTRICULAR NEUROENDOSCOPY 56
7.4.2.1 Ease of use, increased visibility, and treatment of a large number of neurological conditions—key advantages of intraventricular neuroendoscopy 56
7.4.3 TRANSCRANIAL NEUROENDOSCOPY 57
7.4.3.1 Transcranial approach is more invasive as compared to the transnasal neuroendoscopic approach 57
8 NEUROSURGERY DEVICES MARKET, BY REGION 58
8.1 INTRODUCTION 59
8.2 NORTH AMERICA 60
8.2.1 US 63
8.2.1.1 The US dominates the North American neurosurgery devices market due to the high prevalence of traumatic brain injuries 63
8.2.2 CANADA 66
8.2.2.1 Favorable government initiatives to support market growth in Canada 66
8.3 EUROPE 69
8.3.1 GERMANY 72
8.3.1.1 The strong presence of key neurosurgery equipment manufacturers to support market growth 72
8.3.2 UK 75
8.3.2.1 High burden of brain tumors to fuel market growth 75
8.3.3 FRANCE 77
8.3.3.1 Rising geriatric population and the associated increase in the prevalence of neurological disorders to drive the demand for neurosurgery devices 77
8.3.4 ROE 80
8.4 ASIA PACIFIC 83
8.5 REST OF THE WORLD 87
?
9 COMPETITIVE LANDSCAPE 91
9.1 OVERVIEW 91
9.2 MARKET SHARE ANALYSIS 92
9.2.1 INTRODUCTION 92
9.3 COMPETITIVE LEADERSHIP MAPPING 94
9.3.1 VISIONARY LEADERS 94
9.3.2 INNOVATORS 95
9.3.3 DYNAMIC DIFFERENTIATORS 95
9.3.4 EMERGING COMPANIES 95
9.4 COMPETITIVE SCENARIO 97
9.4.1 PRODUCT LAUNCHES 97
9.4.2 EXPANSIONS 97
9.4.3 ACQUISITIONS 98
9.4.4 JOINT VENTURES 98
10 COMPANY PROFILES 99
(Business overview, Products offered, Recent developments, MNM view)*
10.1 B. BRAUN MELSUNGEN 99
10.2 MEDTRONIC 101
10.3 BOSTON SCIENTIFIC CORPORATION 103
10.4 NEVRO CORPORATION 105
10.5 KARL STORZ 107
10.6 ABBOTT 108
10.7 ACKERMANN INSTRUMENTE 110
10.8 ADEOR MEDICAL 111
10.9 HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS 112
10.10 MACHIDA ENDOSCOPE CO., LTD. 113
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11 APPENDIX 114
11.1 DISCUSSION GUIDE 114
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 117
11.3 AVAILABLE CUSTOMIZATIONS 119
11.4 RELATED REPORTS 119
11.5 AUTHOR DETAILS 120
